MUC1-mediated induction of myeloid-derived suppressor cells in patients with acute myeloid leukemiaAthalia R. Pyzer, David Avigan, Dina Stroopinsky et al.|Blood|2017Cited by 193
Individualized vaccination of AML patients in remission is associated with induction of antileukemia immunity and prolonged remissionsJacalyn Rosenblatt, David Avigan, Mary Paty Bryant et al.|Science Translational Medicine|2016Cited by 165
Phase 1 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host diseaseMyrna Nahas, Jacalyn Rosenblatt, Robert J. Soiffer et al.|Blood|2018Cited by 48
Phase I/Ib Trial of the MUC1 Inhibitor GO-203-2C Alone and in Combination with Decitabine for Acute Myeloid LeukemiaJessica Liegel, David Avigan, Jacalyn Rosenblatt et al.|Blood|2017Cited by 4
MUC1-C Inhibition Leads to Decrease in PD-L1 Levels Via up-Regulation of Micro RNAsAthalia R. Pyzer, David Avigan, Dina Stroopinsky et al.|Blood|2016Cited by 2